Abzs against myelin basic protein (MBP) and myelin oligodendrocyte glycoprotein (MOG) possessing proteolytic activity in MS and SLE patients may attack specific proteins of the axon myelin-proteolipid sheath. The gene discussed is MOG; the disease is myeloid sarcoma.